Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics buy Leerink Partnrs

Start price
€198.50
07.02.24 / 50%
Target price
-
07.02.25
Performance (%)
25.49%
Price
€249.10
16:34
Summary
This prediction is currently active. The prediction currently has a performance of 25.49%. This prediction currently runs until 07.02.25. The prediction end date can be changed by Leerink_Partnrs at any time. Leerink_Partnrs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
United Therapeutics 2.075% 2.075%
iShares Core DAX® -0.654% 1.989%
iShares Nasdaq 100 0.903% 5.664%
iShares Nikkei 225® -0.740% -1.363%
iShares S&P 500 -0.013% 3.020%

Comments by Leerink_Partnrs for this prediction

In the thread United Therapeutics diskutieren

United Therapeutics Co. (NASDAQ: UTHR) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Ratings data for UTHR provided by MarketBeat